GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Shiller PE Ratio

Taisho Pharmaceutical Holdings Co (TSE:4581) Shiller PE Ratio : 735,254,421.17 (As of Apr. 29, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Shiller PE Ratio?

As of today (2024-04-29), Taisho Pharmaceutical Holdings Co's current share price is 円231891891891.89. Taisho Pharmaceutical Holdings Co's E10 for the quarter that ended in Dec. 2023 was 円315.39. Taisho Pharmaceutical Holdings Co's Shiller PE Ratio for today is 735,254,421.17.

The historical rank and industry rank for Taisho Pharmaceutical Holdings Co's Shiller PE Ratio or its related term are showing as below:

TSE:4581' s Shiller PE Ratio Range Over the Past 10 Years
Min: 99999999.99   Med: 99999999.99   Max: 99999999.99
Current: 99999999.99

During the past years, Taisho Pharmaceutical Holdings Co's highest Shiller PE Ratio was 99999999.99. The lowest was 99999999.99. And the median was 99999999.99.

TSE:4581's Shiller PE Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 24.63 vs TSE:4581: 99999999.99

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Taisho Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円34.990. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円315.39 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Taisho Pharmaceutical Holdings Co Shiller PE Ratio Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Shiller PE Ratio Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,000,000.00 10,000,000.00 10,000,000.00 10,000,000.00 10,000,000.00

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,000,000.00 10,000,000.00 10,000,000.00 10,000,000.00 10,000,000.00

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Shiller PE Ratio falls into.



Taisho Pharmaceutical Holdings Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Taisho Pharmaceutical Holdings Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=231891891891.89/315.39
=735,254,421.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taisho Pharmaceutical Holdings Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Taisho Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=34.99/106.8000*106.8000
=34.990

Current CPI (Dec. 2023) = 106.8000.

Taisho Pharmaceutical Holdings Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 59.840 95.700 66.781
201406 82.100 98.000 89.472
201409 73.210 98.500 79.379
201412 86.930 97.900 94.833
201503 60.270 97.900 65.749
201506 57.780 98.400 62.712
201509 81.310 98.500 88.162
201512 91.520 98.100 99.636
201603 46.980 97.900 51.251
201606 86.860 98.100 94.563
201609 81.960 98.000 89.320
201612 127.190 98.400 138.048
201703 63.910 98.100 69.578
201706 69.210 98.500 75.042
201709 81.050 98.800 87.613
201712 180.660 99.400 194.110
201803 65.280 99.200 70.281
201806 171.350 99.200 184.478
201809 359.790 99.900 384.640
201812 112.190 99.700 120.179
201903 -35.130 99.700 -37.632
201906 137.770 99.800 147.433
201909 47.250 100.100 50.413
201912 37.650 100.500 40.010
202003 29.770 100.300 31.699
202006 75.890 99.900 81.132
202009 65.450 99.900 69.971
202012 36.780 99.300 39.558
202103 -11.510 99.900 -12.305
202106 14.750 99.500 15.832
202109 21.150 100.100 22.566
202112 74.400 100.100 79.380
202203 50.630 101.100 53.485
202206 70.080 101.800 73.522
202209 62.440 103.100 64.681
202212 122.080 104.100 125.246
202303 -23.200 104.400 -23.733
202306 53.150 105.200 53.958
202309 37.610 106.200 37.822
202312 34.990 106.800 34.990

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Taisho Pharmaceutical Holdings Co  (TSE:4581) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Taisho Pharmaceutical Holdings Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines